Loading…
Huntsman Corporation
NYSE: HUN Materials Chemicals 🔎 Screen
$1.7B
Market Cap
44.1
P/E
2.81
PEG
-3.0%
ROCE
-7.1%
ROE
0.67
D/E
-2.3%
OPM
-40.0%
% from 52W High
23
α RS
⚖️ Compare 🔒 Generate Report 🔒 Research Packet 📚 Guides
🌏 Global Investor Returns
Currency-adjusted total returns for HUN including FX impact
🌏
Click 🌏 Returns tab to load data
📈 Price History
Ratio Health
Excellent
Good
Average
Poor
By Category
📊 Sector Averages
About

Huntsman Corporation manufactures and sells diversified organic chemical products worldwide.

Key Ratios Snapshot
📈 Growth Pattern
📊 Quick Scorecard
Loading…
🔒
Premium Feature
AI-generated 10-section company profile — business model, financials, strengths, risks & management quality
Upgrade to Premium
Already a member? Log in
📐
3-Statement Financial Model
Bear / Base / Bull projections · DCF fair value · Reverse-DCF
Open Model →
🎙 Management Tone Mixed ↑ Improving 4 quarters Full tone analysis in Intelligence →
📊 MIXED Huntsman aggressively raising prices, sees stronger Q2 orders amid supply disruptions
Revenue & Profitability
Exact revenue, net income, and operating income figures for Q1 2026 were not provided in the call. Management noted that Polyurethanes EBITDA margins remain below mid-cycle levels. Guidance for Performance Products Q2 EBITDA is $30M-$40M. The company expects to offset over $100M in raw material cost increases in Q2 through pricing actions. Europe is expected to be positive EBITDA in the second quarter.
Outlook
Management sees stronger-than-expected demand in Q2 but questions sustainability beyond June, citing inflation and potential consumer spending shifts. They are focused on raising prices to cover raw material costs and expanding margins. Peter Huntsman noted a 'bit of euphoria' in the industry but warned of eventual downward pressure later in the year due to inflation. Supply chains are being reassessed, potentially leading to lasting shifts in trade flows.
Growth Drivers
Key growth drivers include the construction season in North America, Europe, and Asia; pre-buying ahead of announced price increases; and supply disruptions that are diverting customers from Chinese maleic suppliers to Huntsman’s U.S. production. Advanced Materials is benefiting from recovery in aerospace and power markets, which are expected to continue growing above GDP growth. The specialty amines capacity addition for semiconductors is ramping up and expected to contribute $5M+ in 2026.
Balance Sheet & CapEx
Not discussed in this earnings call. The only investment mentioned is the specialty amines capacity for semiconductors, which is currently in qualification and expected to reach a normalized run rate by end of 2026, contributing $5M+ this year.
Margins
Polyurethanes EBITDA margins are still below mid-cycle levels, which the company targets in the mid-teens percent. In Q2, they expect to stay ahead of raw material cost increases. Performance Products EBITDA guidance of $30M-$40M reflects pricing exceeding raw material costs. Europe is expected to be positive EBITDA in Q2. The company is working to continuously push price increases to recover raw material inflation and expand margins.
Key Risks
Key risks identified include: sustainability of demand beyond Q2 due to inflation and consumer spending shifts; volatility in raw material costs (particularly benzene and energy); geopolitical instability in the Middle East affecting supply chains and shipping; European energy costs remaining high; and the possibility of pre-buying pulling forward demand, leading to a subsequent slowdown. Management also flagged an 11% drop in March U.S. residential permits as a cautionary indicator for construction.
Generated by AI · Q1 2026 results · Not investment advice
🔒
Free Account Required

Create a free Finmagine account to access Finmagine™ Scorecard.

See how this company scores across 5 dimensions — Financial Health, Growth Prospects, Competitive Position, Management Quality, and Valuation — powered by 30+ computed ratios.

Create Free AccountLog In
🔒
Premium Feature

Upgrade to Finmagine Premium to unlock Ask AI.

Get 25 expert AI analysis templates — Business KPIs, Comprehensive, Forensic Governance, Peer Comparison, Risk-Reward, Full Research Report, IPO Decoder, Red Flag Detector, and more — ready to paste into ChatGPT, Claude, Gemini, or Perplexity.

Upgrade to PremiumCreate Free Account
🔒
Premium Feature

Upgrade to Finmagine Premium to unlock Peer Comparison.

Compare this company side-by-side against its sector peers with financial metrics, ratio benchmarking, and relative performance across all key dimensions.

Upgrade to PremiumCreate Free Account
✓ 📞 Earnings Call Transcripts (5 quarters) submit a missing quarter
🔍
🔎 See cross-company document search → ?
📞 Earnings Call Transcripts (5)
Q2 2026 Q2 2026 2026-07-31
Margins and EBITDA improved year-over-year, with strong growth in Advanced Materials and Polyurethanes. The Olin merger is expected to deliver $300 million in synergies and further strengthen the balance sheet, while macroeconomic and energy market volatility remain key risks.
Q1 2026 Q1 2026 2026-05-01
Aggressive price increases and strong demand are driving margin recovery, especially in Polyurethanes, with Q2 expected to show the first positive price mix since 2022. Risks remain around inflation, supply disruptions, and demand sustainability.
Q4 2025 Q4 2025 2026-02-18
2025 saw significant cost reductions and facility closures amid global headwinds, with 45% EBITDA conversion to free cash flow and early signs of recovery in 2026. Polyurethanes and advanced materials segments show cautious optimism, while industry consolidation and strategic flexibility remain priorities.
Q3 2025 Q3 2025 2025-11-07
Aggressive cost and cash management continues amid unprecedented macro challenges in the U.S., China, and Europe. Dividend cut by 65% to preserve balance sheet, with $100 million in cost savings on track and further inventory reductions prioritized. Advanced materials and U.S. spray foam show relative strength.
Q2 2025 Q2 2025 2025-08-01
Q2 results met expectations, with advanced materials rebounding and polyurethanes pressured by weak construction and tariffs. Cash flow was positive due to working capital actions, but volumes and prices remain below normal. Outlook is stable but cautious, with focus on cost control and balance sheet strength.
🔒
Premium Feature

Upgrade to Finmagine Premium to unlock Catalyst Timeline.

Every result, order win, insider trade, ECS update, earnings-call, and SEC announcement for this company — in one chronological lane.

Upgrade to PremiumCreate Free Account
🔒
Premium Feature

Upgrade to Finmagine Premium to unlock Full Report.

Read the complete Finmagine™ investment research report — comprehensive fundamental analysis, business model assessment, competitive positioning, and investment recommendation.

Upgrade to PremiumCreate Free Account

📊 Analysis Methodology

This comprehensive investment analysis was conducted using The Finmagine™ Stock Analysis & Ranking Methodology, a proprietary framework that systematically evaluates stocks across five critical dimensions: Financial Health, Growth Prospects, Competitive Positioning, Management Quality, and Valuation.

🎯
Discover Our Proven Investment Framework Learn how we analyze and rank stocks using advanced quantitative models, multi-dimensional scoring systems, and dynamic discriminatory ranking techniques that have guided successful investment decisions across market cycles.
📊 Explore The Finmagine™ Methodology

A comprehensive, bias-free framework for analyzing and ranking stocks by Financial Strength, Growth Potential, Competitive Edge, Management Quality, and Value.

Financial Model
Projections are built from each company's audited annual financials (Income Statement, Balance Sheet, Cash Flow) over the last 5 fiscal years. Forward assumptions — revenue growth %, EBITDA margin, D&A (USD millions), interest expense, tax rate, and capex — are AI-generated using historical context and refreshed twice a year: after the December results season and after the September/Q4 results season.

DCF Valuation
Fair Value = Σ(FCFt / (1+WACC)t) + Terminal Value. Terminal Value uses the Gordon Growth Model: FCF5 × (1+g) / (WACC−g). Default WACC: 10% (US risk-free ~4.5%, equity risk premium ~5.5%). Default terminal growth: 3% (long-run US nominal GDP proxy).

CAGR Tracker
Expected 5-year CAGR = (DCF Fair Value / Current Price)1/5 − 1. Assumes fair value is reached in exactly 5 years — a mechanical estimate only.

Data Sources & Limitations
Financial statements sourced from public filings. Prices updated daily. Forward assumptions are AI-generated. All monetary values in USD millions. Non-US ADR companies may have currency conversion inaccuracies. Models are point-in-time and do not update intra-quarter or account for M&A, macro shocks, or extraordinary items.

⚠️ Important Disclaimers — Please read without fail.

Investment Risk:
Investing in securities, including US equities and ETFs, involves inherent risks including the potential loss of principal. All investments are subject to market fluctuations, economic conditions, regulatory changes, and other factors that may affect their value. Past performance is not indicative of future results. This analysis is provided for informational and educational purposes only and should not be construed as investment advice under any circumstances.

No Investment Recommendation:
This analysis does not constitute, nor should it be interpreted as, an offer, solicitation, or recommendation to buy, sell, or hold any securities or financial products. Investors are strongly advised to conduct their own independent research and due diligence and to consult with a licensed financial advisor or an SEC-registered investment adviser before making any investment decisions, taking into account their individual financial situation, risk tolerance, and investment objectives.

Not SEC-Registered:
Finmagine is not registered as an investment adviser with the U.S. Securities and Exchange Commission (SEC) or any state securities authority. Nothing on this platform constitutes investment advice as defined under the Investment Advisers Act of 1940.

Conflict of Interest Disclosure:
The author and/or analyst may currently hold or have previously held positions in the securities discussed. Any such positions are not intended to influence the objectivity or independence of the analysis. This research is produced independently and is not sponsored, endorsed, or commissioned by any company or institution.

Information Sources:
The analysis is based on publicly available information including SEC filings (10-K, 10-Q), annual reports, management commentary, and publicly available financial data. Information is believed to be accurate as of the date of publication but may be subject to change without notice. Readers are encouraged to independently verify all information before acting upon it.

Forward-Looking Statements:
This analysis may contain forward-looking statements, forecasts, or projections that are inherently subject to risks, uncertainties, and assumptions. Actual results may differ materially from those expressed or implied. Finmagine does not undertake any obligation to update such statements in the future.

Limitation of Liability:
The content is provided "as is" without any warranties, express or implied. Finmagine expressly disclaims any liability for errors, omissions, or any losses incurred as a result of reliance on the information provided. Readers assume full responsibility for their investment decisions.